Logo image of KPRX

KIORA PHARMACEUTICALS INC (KPRX) Stock Earnings & Estimates

NASDAQ:KPRX - US49721T5074 - Common Stock

2.68 USD
-0.05 (-1.83%)
Last: 9/5/2025, 8:26:26 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
KPRX revenue by date.KPRX revenue by date.
16.02M1.53M
-90.45%
765K
-50.00%

-100.00%
23.231M68.735M
195.88%
171.13M
148.97%
243.19M
42.11%
306.5M
26.03%
EBITDA
YoY % growth
KPRX ebitda by date.KPRX ebitda by date.
-12.27M
-20.89%
-10.631M
13.36%
6.538M
161.50%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KPRX ebit by date.KPRX ebit by date.
-12.31M
-20.69%
-10.683M
13.22%
6.518M
161.02%
-10.569M
-262.15%
-15.624M
-47.82%
-27.336M
-74.96%
-7.666M
71.96%
31.825M
515.13%
117.86M
270.34%
181.25M
53.78%
242.03M
33.53%
Operating Margin
KPRX operating margin by date.KPRX operating margin by date.
N/AN/A40.69%-690.80%-2,042.33%N/A-33.00%46.30%68.87%74.53%78.97%
EPS
YoY % growth
KPRX eps by date.KPRX eps by date.
-232.11
61.43%
-28.35
87.79%
1.04
103.67%
-2.46
-336.86%
-2.44
1.04%
-2.10
13.81%
-0.19
90.78%
5.65
3,015.79%
16.49
191.88%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.67
16.89%
-0.69
33.31%
-0.57
-8.87%
-0.68
-26.56%
-0.59
12.12%
-0.60
13.24%
Revenue
Q2Q % growth
765K765K765K
-100.00%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-2.8M
-75.63%
-2.896M
-12.91%
-3.428M
-47.11%
-5.173M
-115.90%
-5.605M
-100.18%
-5.82M
-100.99%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.54
-1.89%
-0.620.0812.49%
Q1 2025
Q2Q % growth
-0.52
-115.20%
-0.680.1623.91%
Q4 2024
Q2Q % growth
-1.04
75.41%
-0.56-0.48-85.38%
Q3 2024
Q2Q % growth
-0.81
89.89%
-0.78-0.03-3.94%
Q2 2024
Q2Q % growth
-0.53
92.55%
-0.870.3439.35%
Q1 2024
Q2Q % growth
3.42
138.00%
-0.614.03664.47%
Q4 2023
Q2Q % growth
-4.23
73.25%
-3.84-0.39-10.10%
Q3 2023
Q2Q % growth
-8.01
85.25%
-3.24-4.77-146.95%
Q2 2023
Q2Q % growth
-7.11
89.03%
-9.782.6727.31%
Q1 2023
Q2Q % growth
-9.00
90.74%
-15.476.4741.82%
Q4 2022
Q2Q % growth
-15.81
93.36%
-22.586.7729.97%
Q3 2022
Q2Q % growth
-54.30
47.99%
-35.21-19.09-54.23%
Q2 2022
Q2Q % growth
-64.80
48.57%
-73.448.6411.76%
Q1 2022
Q2Q % growth
-97.20
27.03%
-86.29-10.91-12.64%
Q4 2021
Q2Q % growth
-238.26
-27.27%
-84.46-153.80-182.11%
Q3 2021
Q2Q % growth
-104.40
34.09%
-123.6319.2315.55%
Q2 2021
Q2Q % growth
-126.00
7.89%
-153.0027.0017.65%
Q1 2021
Q2Q % growth
-133.20 -141.378.175.78%
Q4 2020
Q2Q % growth
-187.20
27.27%
-161.57-25.63-15.86%
Q3 2020
Q2Q % growth
-158.40 -154.22-4.18-2.71%
Q2 2020
Q2Q % growth
-136.80
36.67%
-157.9021.1013.36%
Q4 2019
Q2Q % growth
-257.40 -297.4340.0313.46%
Q2 2019
Q2Q % growth
-216.00 -275.4059.4021.57%
Q1 2019
Q2Q % growth
54.00 -275.40329.40119.61%
KPRX Yearly EPS VS EstimatesKPRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2K -4K -6K -8K -10K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth

-100.00%
765K-765K-100.00%
Q1 2025
Q2Q % growth

-100.00%
765K-765K-100.00%
Q4 2024
Q2Q % growth
765K-765K-100.00%
Q3 2024
Q2Q % growth
7.14K-7.14K-100.00%
Q4 2021
Q2Q % growth

-100.00%
%
Q1 2020
Q2Q % growth

-100.00%
%
KPRX Yearly Revenue VS EstimatesKPRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2024 2025 2026 2028 2029 2030 2031 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-28.16% 5.71% -12.59% 3.4%
Revenue0% N/A -33.33% -33.33%